Management of seizures in the critically III

Neurologist

Volumn 12, Issue 3, 2006, Pages 127-139

  Varelas, Panayiotis N ^a   Spanaki, Marianna ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Alcohol; Electrolytes; Head trauma; Intensive care unit; Intracerebral hemorrhage; New antiepileptics; Seizures; Stroke; Subarachnoid hemorrhage

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; ETIRACETAM; FOSPHENYTOIN SODIUM; GABAPENTIN; LAMOTRIGINE; MIDAZOLAM; NEW DRUG; OXCARBAZEPINE; PARALDEHYDE; PENTOBARBITAL; PHENYTOIN; PROPOFOL; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

BRAIN HEMORRHAGE; BRAIN INJURY; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; HEAD INJURY; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SEIZURE; STROKE; SUBARACHNOID HEMORRHAGE;

ALCOHOLISM; ANTICONVULSANTS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CRITICAL ILLNESS; ELECTROENCEPHALOGRAPHY; ELECTROLYTES; HUMANS; MULTIPLE ORGAN FAILURE; SEIZURES; SUBARACHNOID HEMORRHAGE; SUBSTANCE-RELATED DISORDERS;

EID: 33646759951     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.nrl.0000195827.34370.63     Document Type: Review

References (165)

1. Mirski MA, Varelas PN. Diagnosis and treatment of seizures in the adult intensive care unit. Contemp Crit Care. 2003;1:1-12.
2. Varelas PN, Mirski MA. Seizures in the adult intensive care unit. J Neurosurg Anesthesiol. 2001;13:163-175.
3. Seizures in critical care: a guide to diagnosis and therapeutics. In: Varelas PN, ed. NJ: Humana Press; 2004.
4. Bleck TP, Smith MC, Pierre-Louis SJ, et al. Neurologic complications of critical medical illnesses. Crit Care Med. 1993;21:98-103.
5. Towne AR, Waterhouse EJ, Boggs JG, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology. 2000;54:340-345.
6. Claassen J, Mayer SA, Kowalski RG, et al. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004;62:1743-1748.
7. Jordan KG. Continuous EEG monitoring in the neuroscience intensive care unit and emergency department. J Clin Neurophysiol. 1999;16:14-39.
8. Wallace KL. Antibiotic-induced convulsions. Crit Care Clin. 1997;13:741-762.
9. Somjen GG. Low external NaCl concentration and low osmolarity enhance voltage-gated Ca currents but depress K currents in freshly isolated rat hippocampal neurons. Brain Res. 1999;851:189-197.
10. Somjen GG. Ion regulation in the brain: implications for pathophysiology. Neuroscientist. 2002;8:254-267.
11. Bladin CF, Alexandrov AV, Bellavance A, et al. Seizures after stroke: a prospective multicenter study. Arch Neurol. 2000;57:1617-1622.
12. Burn J, Dennis M, Bamford J, et al. Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ. 1997;315:1582-1587.
13. Kilpatrick CJ, Davis SM, Tress BM, et al. Epileptic seizures in acute stroke. Arch Neurol. 1990;47:157-160.
14. Hauser WA, Kurland LT. The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia. 1975;16:1-66.
15. Milandre L, Broca P, Sambuc R, et al. [Epileptic crisis during and after cerebrovascular diseases: a clinical analysis of 78 cases]. Rev Neurol. 1992;148:767-772.
16. Arboix A, Comes E, Massons J, et al. Relevance of early seizures for in-hospital mortality in acute cerebrovascular disease. Neurology. 1996;47:1429-1435.
17. Reith J, Jorgensen HS, Nakayama H, et al. Seizures in acute stroke: predictors and prognostic significance: the Copenhagen Stroke Study. Stroke. 1997;28:1585-1589.
18. Back T, Ginsberg MD, Dietrich WD, et al. Induction of spreading depression in the ischemic hemisphere following experimental middle cerebral artery occlusion: effect on infarct morphology. J Cereb Blood Flow Metab. 1996;16:202-213.
19. Sun DA, Sombati S, DeLorenzo RJ. Glutamate injury-induced epileptogenesis in hippocampal neurons: an in vitro model of stroke-induced "epilepsy." Stroke. 2001;32:2344-2350.
20. Lancman ME, Golimstok A, Norscini J, et al. Risk factors for developing seizures after a stroke. Epilepsia. 1993;34:141-143.
21. Lamy C, Domigo V, Semah F, et al. Early and late seizures after cryptogenic ischemic stroke in young adults. Neurology. 2003;60:400-404.
22. Paolucci S, Silvestri G, Lubich S, et al. Poststroke late seizures and their role in rehabilitation of inpatients. Epilepsia. 1997;38:266-270.
23. Berges S, Moulin T, Berger E. et al. Seizures and epilepsy following strokes: recurrence factors. Eur Neurol. 2000;43:3-8.
24. Cleary P, Shorvon S, Tallis R. Late-onset seizures as a predictor of subsequent stroke. Lancet. 2004;363:1184-1186.
25. Labovitz DL, Hauser WA, Sacco RL. Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology. 2001;57:200-206.
26. Rumbach L, Sablot D, Berger E, et al. Status epilepticus in stroke: report on a hospital-based stroke cohort. Neurology. 2000;54:350-354.
27. Sung CY, Chu NS. Epileptic seizures in thrombotic stroke. J Neurol. 1990;237:166-170.
28. Adams HP Jr, Adams RJ, Brott T, et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003;34:1056-1083.
29. Tissue plasminogen activator for acute ischemic stroke: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
30. Devuyst G, Karapanayiotides T, Hottinger I, et al. Prodromal and early epileptic seizures in acute stroke: does higher serum cholesterol protect? Neurology. 2003;61:249-252.
31. Gilad R, Lampl Y, Eschel Y, et al. Antiepileptic treatment in patients with early postischemic stroke seizures: a retrospective study. Cerebrovasc Dis. 2001;12:39-43.
32. Leker RR, Neufeld MY. Anti-epileptic drugs as possible neuroprotectants in cerebral ischemia. Brain Res Brain Res Rev. 2003;42:187-203.
33. Goldstein LB. Potential effects of common drugs on stroke recovery. Arch Neurol. 1998;55:454-456.
34. Silverman IE, Restrepo L, Mathews GC. Poststroke seizures. Arch Neurol. 2002;59:195-201.
35. Giroud M, Gras P, Fayolle H, et al. Early seizures after acute stroke: a study of 1,640 cases. Epilepsia. 1994;35:959-964.
36. Sung CY, Chu NS. Epileptic seizures in intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 1989;52:1273-1276.
37. Faught E, Peters D, Bartolucci A, et al. Seizures after primary intracerebral hemorrhage. Neurology. 1989;39:1089-1093.
38. Passero S, Rocchi R, Rossi S, et al. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia. 2002;43:1175-1180.
39. Tatu L, Moulin T, El Mohamad R, et al. Primary intracerebral hemorrhages in the Besancon stroke registry: initial clinical and CT findings, early course and 30-day outcome in 350 patients. Eur Neurol. 2000;43:209-214.
40. Vespa PM, O'Phelan K, Shah M, et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology. 2003;60:1441-1446.
41. Daniele O, Caravaglios G, Ferraro G, et al. Stroke-related seizures and the role of cortical and subcortical structures. J Epilepsy. 1996;9:184-188.
42. Eng JA, Frosch MP, Choi K, et al. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol. 2004;55:250-256.
43. Ogilvy CS, Stieg PE, Awad I, et al. AHA scientific statement: recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke. 2001;32:1458-1471.
44. Lazar RM, Connaire K, Marshall RS, et al. Developmental deficits in adult patients with arteriovenous malformations. Arch Neurol. 1999;56:103-106.
45. Schauble B, Cascino GD, Pollock BE, et al. Seizure outcomes after stereotactic radiosurgery for cerebral arteriovenous malformations. Neurology. 2004;63:683-687.
46. Broderick JP, Adams HP Jr, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1999;30:905-915.
47. Berger AR, Lipton RB, Lesser ML, et al. Early seizures following intracerebral hemorrhage: implications for therapy. Neurology. 1988;38:1363-1365.
48. Diringer MN. Intracerebral hemorrhage: pathophysiology and management. Crit Care Med. 1993;21:1591-1603.
49. Cervoni L, Artico M, Salvati M, et al. Epileptic seizures in intracerebral hemorrhage: a clinical and prognostic study of 55 cases. Neurosurg Rev. 1994;17:185-188.
50. Qureshi AI, Tuhrim S, Broderick JP, et al. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344:1450-1460.
51. Haines SJ. Decerebrate posturing misinterpreted as seizure activity. Am J Emerg Med. 1988;6:173-177.
52. Ohman J. Hypertension as a risk factor for epilepsy after aneurysmal subarachnoid hemorrhage and surgery. Neurosurgery. 1990;27:578-581.
53. Pinto AN, Canhao P, Ferro JM. Seizures at the onset of subarachnoid haemorrhage. J Neurol. 1996;243:161-164.
54. Hasan D, Schonck RS, Avezaat CJ, et al. Epileptic seizures after subarachnoid hemorrhage. Ann Neurol. 1993;33:286-291.
55. Butzkueven H, Evans AH, Pitman A, et al. Onset seizures independently predict poor outcome after subarachnoid hemorrhage. Neurology. 2000;55:1315-1320.
56. Claassen J, Peery S, Kreiter KT, et al. Predictors and clinical impact of epilepsy after subarachnoid hemorrhage. Neurology. 2003;60:208-214.
57. Hart RG, Byer JA, Slaughter JR, et al. Occurrence and implications of seizures in subarachnoid hemorrhage due to ruptured intracranial aneurysms. Neurosurgery. 1981;8:417-421.
58. Zambrelli E, Cavallini A, Tosi P, et al. A possible case of unruptured middle cerebral artery aneurysm presenting as epileptic seizures. Neurol Sci. 2003;24:141-144.
59. Miele VJ, Bendok BR, Batjer HH. Unruptured aneurysm of the middle cerebral artery presenting with psychomotor seizures: case study and review of the literature. Epilepsy Behav. 2004;5:420-428.
60. Kamali AW, Cockerell OC, Butlar P. Aneurysms and epilepsy: an increasingly recognised cause. Seizure. 2004;13:40-44.
61. Rhoney DH, Tipps LB, Murry KR, et al. Anticonvulsant prophylaxis and timing of seizures after aneurysmal subarachnoid hemorrhage. Neurology. 2000;55:258-265.
62. Rosengart AJ, Novakovic R, Dezheng H, et al. Impact of prophylactic anticonvulsive use on outcome in subarachnoid hemorrhage. Stroke. 2004;35:250.
63. Foy PM, Chadwick DW, Rajgopalan N, et al. Do prophylactic anticonvulsant drugs alter the pattern of seizures after craniotomy? J Neurol Neurosurg Psychiatry. 1992;55:753-757.
64. Baker CJ, Prestigiacomo CJ, Solomon RA. Short-term perioperative anticonvulsant prophylaxis for the surgical treatment of low-risk patients with intracranial aneurysms. Neurosurgery. 1995;37:863-870.
65. Byrne JV, Boardman P, Ioannidis I, et al. Seizures after aneurysmal subarachnoid hemorrhage treated with coil embolization. Neurosurgery. 2003;52:545-552.
66. Maramattom BV, Britton J, Wijdicks EFM. Ictal bradycardia after endovascular aneurysm treatment. Neurocrit Care. 2004;1:265.
67. Lawn ND, Bamlet WR, Radhakrishnan K, et al. Injuries due to seizures in persons with epilepsy: a population-based study. Neurology. 2004;63:1565-1570.
68. Salazar AM, Jabbari B, Vance SC, et al. Epilepsy after penetrating head injury, I: clinical correlates: a report of the Vietnam Head Injury Study. Neurology. 1985;35:1406-1414.
69. Lee ST, Lui TN, Wong CW, et al. Early seizures after moderate closed head injury. Acta Neurochir (Wien). 1995;137:151-154.
70. Vespa PM, Nuwer MR, Nenov V, et al. Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring. J Neurosurg. 1999;91:750-760.
71. Hudak AM, Trivedi K, Harper CR, et al. Evaluation of seizure-like episodes in survivors of moderate and severe traumatic brain injury. J Head Trauma Rehabil. 2004;19:290-295.
72. Frey LC. Epidemiology of posttraumatic epilepsy: a critical review. Epilepsia. 2003;44(suppl 10):11-17.
73. Temkin NR. Risk factors for posttraumatic seizures in adults. Epilepsia. 2003;44(suppl 10):18-20.
74. Ottman R, Lee JH, Risch N, et al. Clinical indicators of genetic susceptibility to epilepsy. Epilepsia. 1996;37:353-361.
75. Diaz-Arrastia R, Gong Y, Fair S, et al. Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele. Arch Neurol. 2003;60:818-822.
76. Temkin NR, Dikmen SS, Wilensky AJ, et al. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med. 1990;323:497-502.
77. Temkin NR, Dikmen SS, Anderson GD, et al. Valproate therapy for prevention of posttraumatic seizures: a randomized trial. J Neurosurg. 1999;91:593-600.
78. The Brain Trauma Foundation. The American Association of Neurological Surgeons: the Joint Section on Neurotrauma and Critical Care: role of antiseizure prophylaxis following head injury. J Neurotrauma. 2000;17:549-553.
79. Chang BS, Lowenstein DH. Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2003;60:10-16.
80. Brophy GM, Tesoro EP, Schrote GL, et al. Pharmacist impact on posttraumatic seizure prophylaxis in patients with head injury. Pharmacotherapy. 2002;22:251-255.
81. Hillbom M, Pieninkeroinen I, Leone M. Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management. CNS Drugs. 2003;17:1013-1030.
82. McIntosh C, Chick J. Alcohol and the nervous system. J Neurol Neurosurg Psychiatry. 2004:75(suppl 3):iii16-21.
83. Shirley RL, Walter NA, Reilly MT, et al. MPDZ is a quantitative trait gene for drug withdrawal seizures. Nat Neurosci. 2004;7:699-700.
84. Holloway HC, Hales RE, Watanabe HK. Recognition and treatment of acute alcohol withdrawal syndromes. Psychiatr Clin North Am. 1984;7:729-743.
85. Rathlev NK, Ulrich A, Fish SS, et al. Clinical characteristics as predictors of recurrent alcohol-related seizures. Acad Emerg Med. 2000;7:886-891.
86. Booth BM, Blow FC. The kindling hypothesis: further evidence from a U.S. national study of alcoholic men. Alcohol Alcohol. 1993;28:593-598.
87. Reynolds K, Lewis B, Nolen JD, et al. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003;289:579-588.
88. Freedland ES, McMicken DB. Alcohol-related seizures, part I: pathophysiology, differential diagnosis, and evaluation. J Emerg Med. 1993;11:463-473.
89. Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology. 1993;43:483-488.
90. Hulme J, Sherwood N. Severe lactic acidosis following alcohol related generalised seizures. Anaesthesia. 2004;59:1228-1230.
91. Mattson RH. Parenteral antiepileptic/anticonvulsant drugs. Neurology. 1996;46:S8-13.
92. Freedland ES, McMicken DB. Alcohol-related seizures, part II: clinical presentation and management. J Emerg Med. 1993;11:605-618.
93. Lineaweaver WC, Anderson K, Hing DN. Massive doses of midazolam infusion for delirium tremens without respiratory depression. Crit Care Med. 1988;16:294-295.
94. Galvin GM, Jelinek GA. Midazolam: an effective intravenous agent for seizure control. Arch Emerg Med. 1987;4:169-172.
95. Hillbom M, Tokola R, Kuusela V, et al. Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid. Alcohol. 1989;6:223-226.
96. Alldredge BK, Lowenstein DH, Simon RP. Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures. Am J Med. 1989;87:645-648.
97. Rathlev NK, D'Onofrio G, Fish SS, et al. The lack of efficacy of phenytoin in the prevention of recurrent alcohol-related seizures. Ann Emerg Med. 1994;23:513-518.
98. Alldredge BK, Lowenstein DH. Status epilepticus related to alcohol abuse. Epilepsia. 1993;34:1033-1037.
99. Kumar A, Bleck TP. Intravenous midazolam for the treatment of refractory status epilepticus. Crit Care Med. 1992;20:483-488.
100. Rosenstein DL, Nelson JC, Jacobs SC. Seizures associated with antidepressants: a review. J Clin Psychiatry. 1993;54:289-299.
101. Wah MF, Wah LS. Generalized seizure in a Mauritian woman taking bupropion. PLoS Med. 2004;1:e15.
102. Alldredge BK. Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations. Neurology. 1999;53:S68-75.
103. Lee KC, Finley PR, Alldredge BK. Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings. Expert Opin Drug Saf. 2003;2:233-247.
104. Pisani F, Oteri G, Costa C, et al. Effects of psychotropic drugs on seizure threshold. Drug Saf. 2002;25:91-110.
105. Modica PA, Tempelhoff R, White PF. Pro-and anticonvulsant effects of anesthetics (part 1). Anesth Analg. 1990;70:303-315.
106. Wijdicks EF, Sharbrough FW. New-onset seizures in critically ill patients. Neurology. 1993;43:1042-1044.
107. Armstrong PJ, Bersten A. Normeperidine toxicity. Anesth Analg. 1986;65:536-538.
108. DeToledo JC. Lidocaine and seizures. Ther Drug Monit. 2000;22:320-322.
109. So EL, Ruggles KH, Cascino GD, et al. Seizure exacerbation and status epilepticus related to carbamazepine-10,11-epoxide. Ann Neurol. 1994;35:743-746.
110. Osorio I, Reed RC, Peltzer JN. Refractory idiopathic absence status epilepticus: a probable paradoxical effect of phenytoin and carbamazepine. Epilepsia. 2000;41:887-894.
111. Callahan DJ, Noetzel MJ. Prolonged absence status epilepticus associated with carbamazepine therapy, increased intracranial pressure, and transient MRI abnormalities. Neurology. 1992;42:2198-2201.
112. Spiller HA, Carlisle RD. Status epilepticus after massive carbamazepine overdose. J Toxicol Clin Toxicol. 2002;40:81-90.
113. Zagnoni PG, Albano C. Psychostimulants and epilepsy. Epilepsia. 2002;43(suppl 2):28-31.
114. Auer J, Berent R, Weber T, et al. Subarachnoid haemorrhage with "ecstasy" abuse in a young adult. Neurol Sci. 2002;23:199-201.
115. Kramer LD, Locke GE, Ogunyemi A, et al. Cocaine-related seizures in adults. Am J Drug Alcohol Abuse. 1990;16:307-317.
116. McKinney PE, Hauswald M. Paraffin and body-packers. Lancet. 1999;353:239.
117. Smith PE, McBride A. Illicit drugs and seizures. Seizure. 1999;8:441-443.
118. Cluitmans FH, Meinders AE. Management of severe hyponatremia: rapid or slow correction? Am J Med. 1990;88:161-166.
119. Ellis SJ. Severe hyponatraemia: complications and treatment. QJM. 1995;88:905-909.
120. Sterns RH, Cappuccio JD, Silver SM, et al. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol. 1994;4:1522-1530.
121. Soupart A, Decaux G. Therapeutic recommendations for management of severe hyponatremia: current concepts on pathogenesis and prevention of neurologic complications. Clin Nephrol. 1996;46:149-169.
122. Turk EE, Schulz F, Koops E, et al. Fatal hypernatremia after using salt as an emetic-report of three autopsy cases. Leg Med (Tokyo). 2005;7:47-50.
123. Kishaba RG, Losek JD, Eisenberg CS. Seizure following oral rehydration of hypernatremia with water. Clin Pediatr (Phila). 1990;29:239-240.
124. Tonner DR, Schlechte JA. Neurologic complications of thyroid and parathyroid disease. Med Clin North Am. 1993;77:251-263.
125. MacIsaac RJ, Seeman E, Jerums G. Seizures after alendronate. J R Soc Med. 2002;95:615-616.
126. Krimsky WS, Behrens RJ, Kerkvliet GJ. Oncologic emergencies for the internist. Cleve Clin J Med. 2002;69:209-210, 213-214, 216-217.
127. Kastrup O, Maschke M, Wanke I, et al. Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol. 2002;249:1563-1566.
128. Zazzo JF, Troche G, Ruel P, et al. High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function. Intensive Care Med. 1995;21:826-831.
129. Polderman KH, Bloemers FW, Peerdeman SM, et al. Hypomagnesemia and hypophosphatemia at admission in patients with severe head injury. Crit Care Med. 2000;28:2022-2025.
130. Marik PE, Bedigian MK. Refeeding hypophosphatemia in critically ill patients in an intensive care unit: a prospective study. Arch Surg. 1996;131:1043-1047.
131. Lee JL, Sibbald WJ, Holliday RL, et al. Hypophosphatemia associated with coma. CMAJ. 1978;119:143-145.
132. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-1367.
133. Yudkoff M, Daikhin Y, Nissim I, et al. Ketogenic diet, amino acid metabolism, and seizure control. J Neurosci Res. 2001;66:931-940.
134. Hennis A, Corbin D, Fraser H. Focal seizures and non-ketotic hyperglycaemia. J Neurol Neurosurg Psychiatry. 1992;55:195-197.
135. Towne AR, Pellock JM, Ko D, et al. Determinants of mortality in status epilepticus. Epilepsia. 1994;35:27-34.
136. Pellock JM, Marmarou A, DeLorenzo R. Time to treatment in prolonged seizure episodes. Epilepsy Behav. 2004;5:192-196.
137. Mayer SA, Claassen J, Lokin J, et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002;59:205-210.
138. Hodges BM, Mazur JE. Intravenous valproate in status epilepticus. Ann Pharmacother. 2001;35:1465-1470.
139. Rashkin MC, Youngs C, Penovich P. Pentobarbital treatment of refractory status epilepticus. Neurology. 1987;37:500-503.
140. Claassen J, Hirsch LJ, Emerson RG, et al. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43:146-153.
141. Prasad A, Worrall BB, Bertram EH, et al. Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia. 2001;42:380-386.
142. Rossetti AO, Reichhart MD, Schaller MD, et al. Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia. 2004;45:757-763.
143. Walder B, Tramer MR, Seeck M. Seizure-like phenomena and propofol: a systematic review. Neurology. 2002;58:1327-1332.
144. Cremer OL, Moons KG, Bouman EA, et al. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet. 2001;357:117-118.
145. Galdames D, Aguilera M, Fabres L. Midazolam in the treatment of status epilepticus and frequent seizures in adults. Epilepsia. 1997;38:12.
146. Chamberlain JM, Altieri MA, Futterman C, et al. A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children. Pediatr Emerg Care. 1997;13:92-94.
147. Towne AR, DeLorenzo RJ. Use of intramuscular midazolam for status epilepticus. J Emerg Med. 1999;17:323-328.
148. Duncan JS. The promise of new antiepileptic drugs. Br J Clin Pharmacol. 2002;53:123-131.
149. Krauss GL, Simmons-O'Brien E, Campbell M. Successful treatment of seizures and porphyria with gabapentin. Neurology. 1995;45:594-595.
150. Pandey CK, Singh N, Bose N, et al. Gabapentin and propofol for treatment of status epilepticus in acute intermittent porphyria. J Postgrad Med. 2003;49:285.
151. Alvarez-Sabin J, Montaner J, Padro L, et al. Gabapentin in late-onset poststroke seizures. Neurology. 2002;59:1991-1993.
152. Barrueto F Jr, Green J, Howland MA, et al. Gabapentin withdrawal presenting as status epilepticus. J Toxicol Clin Toxicol. 2002;40:925-928.
153. Pisani F, Gallitto G, Di Perri R. Could lamotrigine be useful in status epilepticus? A case report. J Neurol Neurosurg Psychiatry. 1991;54:845-846.
154. Trinka E, Dilitz E, Unterberger I, et al. Nonconvulsive status epilepticus after replacement of valproate with lamotrigine. J Neurol. 2002;249:1417-1422.
155. Guerrini R, Belmonte A, Parmeggiani L, et al. Myoclonic status epilepticus following high-dosage lamotrigine therapy. Brain Dev. 1999;21:420-424.
156. Paul F, Meencke HJ. Levetiracetam in focal epilepsy and hepatic porphyria: a case report. Epilepsia. 2004;45:559-560.
157. Kudin AP, Debska-Vielhaber G, Vielhaber S, et al. The mechanism of neuroprotection by topiramate in an animal model of epilepsy. Epilepsia. 2004;45:1478-1487.
158. Reuber M, Evans J, Bamford JM. Topiramate in drug-resistant complex partial status epilepticus. Eur J Neurol. 2002;9:111-112.
159. Towne AR, Garnett LK, Waterhouse EJ, et al. The use of topiramate in refractory status epilepticus. Neurology. 2003;60:332-334.
160. Bensalem MK, Fakhoury TA. Topiramate and status epilepticus: report of three cases. Epilepsy Behav. 2003;4:757-760.
161. Takano K, Tanaka T, Fujita T, et al. Zonisamide: electrophysiological and metabolic changes in kainic acid-induced limbic seizures in rats. Epilepsia. 1995;36:644-648.
162. Yoshimura I, Kaneko S, Yoshimura N, et al. Long-term observations of two siblings with Lafora disease treated with zonisamide. Epilepsy Res. 2001;46:283-287.
163. Skardoutsou A, Voudris KA, Vagiakou EA. Non-convulsive status epilepticus associated with tiagabine therapy in children. Seizure. 2003;12:599-601.
164. Kellinghaus C, Dziewas R, Ludemann P. Tiagabine-related non-convulsive status epilepticus in partial epilepsy: three case reports and a review of the literature. Seizure. 2002;11:243-249.
165. Gaida-Hommernick B, Rieck K, Runge U. Oxcarbazepine in focal epilepsy and hepatic porphyria: a case report. Epilepsia. 2001;42:793-795.